FDA announces comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy.
from Food and Drug Administration--Press Releases http://ift.tt/2zKlTgd
via IFTTT
No comments:
Post a Comment